research Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
This study estimates the total cost of evaluating and treating polycystic ovary syndrome in reproductive-aged women in the United States to be $4.36 billion, suggesting more liberal screening could be beneficial.

